{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-124150","form_type":"8-K/A","ticker":"ASNS","cik":"0001141284","company_name":"ACTELIS NETWORKS INC","filed_at":"2025-12-22T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.882449+00:00","generated_at":"2026-05-16T12:23:31.148325+00:00","sec_items":["1.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Actelis amends 8-K to state offering proceeds for general corporate purposes","bullets":["Amendment revises prior 8-K (Dec 17, 2025); proceeds now for general corporate purposes not R&D.","Original 8-K stated proceeds intended for pre-clinical/clinical studies; amended to match press release.","No other changes to the original 8-K or its exhibits; filing date December 22, 2025.","Company ticker ASNS; CEO Tuvia Barlev signed the amendment."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-124150","json":"https://secwatch.observer/filing/0001213900-25-124150.json","markdown":"https://secwatch.observer/filing/0001213900-25-124150.md","text":"https://secwatch.observer/filing/0001213900-25-124150.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1141284/000121390025124150/0001213900-25-124150-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1141284/000121390025124150/ea0270510-8ka1_actelis.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T12:23:31.148325+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}